Health Condition 1: null- Vitiligo
Conditions
Interventions
Intervention1: Group A: PTV-6 and PTV-7 oral,
TA 1 local application: Oral administration:
The systemic treatment drugs P.T.V-6 (oral-500mg each) in the dose of 1 TID after food and P.T.V-7 (Oral -5
Sponsors
Central Council for Research in Unani Medicine
Eligibility
Inclusion criteria
Inclusion criteria: 1. Known cases of Vitiligo with any duration of disease, site, extension and distribution of vitiligenous lesions. 2. Either sex, age range 13â??50 years, with or without family history. 3. Willingness to participate in the study and to give written informed consent.
Exclusion criteria
Exclusion criteria: 1. Subjects having any systemic disease and other skin diseases. 2. Subjects with known allergies. 3. Impaired Cardiac, Hepatic and Renal function 4. Use of any other medications of allopathic and alternative system origin for the disease. 5. Concomitant use of any other antioxidants 6. History of hypersensitivity to any of the investigational drugs/herbal medicine. 7. Any medical condition, where physician feels participation in the study could be detrimental to subjects well being. 8. Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| By observation and Digital photography.Timepoint: Baseline, 1st month, 2nd month, 3rd month, 4th month, 5th month, and 6th month | — |
Secondary
| Measure | Time frame |
|---|---|
| Pathological and Biochemical Investigations for safety measures.Timepoint: Before treatment and after treatment | — |
Countries
India
Contacts
Public ContactDr Muawwar Husain Kazmi
Central Research Institute of Unani Medicine
Outcome results
None listed